Avreo (formerly Riptide Technologies) and A-Life Medical have entered into an OEM partnership to integrate A-Life's LifeCode technology into Avreo's ARIIS (advanced radiology integrated Internet solution), both XML-native systems. LifeCode,
Avreo (formerly Riptide Technologies) and A-Life Medical have entered into an OEM partnership to integrate A-Life's LifeCode technology into Avreo's ARIIS (advanced radiology integrated Internet solution), both XML-native systems. LifeCode, based on natural language processing, provides real-time code generation and compliance checking. Avreo intends to use the LifeCode engine to add voice recognition functionality to ARIIS, giving radiologists immediate feedback regarding diagnostic reports. The firms will demonstrate the integrated products at the RSNA meeting.
© 2000 Miller Freeman Inc.
11/29/00, Issue # 117, page 3.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.